Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø

XClose

Brain Sciences

Home
Menu

Technology and licensing

We use our proficiency in brain sciences research to fight disease and create new materials and processes. Technology transfer allows us to maximise the commercial potential of our discoveries and transform lives.
Tenpoint

Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø spinout tackling eye disease announces £57m launch

Tenpoint Therapeutics, which spun out of Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø in 2021, has announced its launch to address degenerative eye diseases.

Paul Whiting DDI

Accelerating dementia drug discovery

AstronauTx is a biotech company that builds on research from the Alzheimer's Research UK Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Drug Discovery Institute (DDI). Launched in 2019, it has attracted £7.5 million of investment. 

eye closeup

Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Brain Sciences spinout is advancing gene therapy treatments

Research originating from the Department of Genetics at the Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Institute of Ophthalmology hopes to treat devastating eye diseases that cause blindness.